Tag Archives: Colorectal

Colorectal Cancer Takes the Life of Far Too Many People and Black Men are Disproportionately Affected

Following the devastating news of the death of the world’s beloved Black Panther, Chadwick Boseman, from colorectal cancer, many were left asking why – and how. What most don’t know is that Chadwick Boseman sat at the intersection of where colorectal cancer rates are among the highest and rising the fastest. He was a young… Read More »

Veg And Fruit For Colorectal Cancer Differs By Site Of Origin

According to a study, how vegetable and fruit consumption impacts colorectal cancer differs by site of origin. The study revealed that within the distal and proximal colon, consumption of brassica vegetables (cabbage, Brussels sprouts, broccoli and cauliflower) were linked to reduced risk of these cancers. A reduced distal colon cancer risk was linked to higher… Read More »

Common hypertension medications may reduce colorectal cancer risk

Research Highlights: People who take angiotensin converting enzyme inhibitors (ACE-i) or angiotensin II receptor blockers (ARBs) for conditions such as high blood pressure were less likely to be diagnosed with colorectal cancer after having a normal colonoscopy. This is the first study to show potential benefits on colorectal cancer development from these commonly prescribed hypertension… Read More »

FDA Approves Braftovi (encorafenib) in Combination with Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer (CRC) After Prior Therapy

Print this page April 8, 2020 – Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved Braftovi® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) for the treatment of adult patients with metastatic colorectal cancer (CRC) with a BRAFV600E mutation, as detected by an FDA-approved test, after prior… Read More »